Yahoo! JAPAN

2024/5/29 -Among these innovations, SMART-C® has emerged as a valuable tool for veterinarians, offering new opportunities to enhance patient care and streamline procedures ...

2023/11/29 -The goal of the KRW 25.5 billion (approx. US$20 million) SMART-C Programme is to promote sustainable maritime transport systems and a sustainable marine ...

2024/4/7 -In brief, SMART-C includes investigators of all large, placebo-controlled, phase 3 outcomes trials of SGLT2i, allowing for sharing of trial data across the ...

2023/8/8 -The SMART-C Github provides a step-by-step guide to modelling GFR slope in R, based on the methods used in the CREDENCE and DAPA-CKD trials. It also includes an ...

2023/7/17 -SMART-C comprises all 13 completed SGLT2 inhibitor outcome trials, which include more than 90,000 patients with diabetes, heart failure or chronic kidney ...

2024/4/5 -EFFECTS OF SGLT2 INHIBITORS ON CARDIOVASCULAR OUTCOMES WITH AND WITHOUT BASELINE USE OF GLP-1 RECEPTOR AGONISTS: A SMART-C COLLABORATIVE META-ANALYSISOpen ...

2024/4/18 -Meta-analysis of 11 phase 3 trials shows SGLT2 inhibitors reduce cardiovascular event risk by 9% across diverse patient populations.

2023/10/25 -This hyper-portable, wireless mini c-arm offers unmatched ergonomic and use-case benefits. Smart-C allows surgeons to use the mini C-arm in the OR and clinic, ...

2024/5/29 -The latest news from Turner Imaging Systems innovative X-ray fluoroscopy device the SMART-C® mini C-arm that provides portability & flexibility.

2024/6/4 -Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation. 2024 Jun 4;149(23): ...